De Carolis, Elena
 Distribuzione geografica
Continente #
NA - Nord America 5.564
EU - Europa 4.371
AS - Asia 2.994
SA - Sud America 654
Continente sconosciuto - Info sul continente non disponibili 146
AF - Africa 109
OC - Oceania 8
Totale 13.846
Nazione #
US - Stati Uniti d'America 5.357
DE - Germania 1.343
SG - Singapore 1.227
CN - Cina 806
IT - Italia 773
SE - Svezia 652
BR - Brasile 519
FR - Francia 351
VN - Vietnam 294
PL - Polonia 286
UA - Ucraina 210
GB - Regno Unito 206
IE - Irlanda 141
TR - Turchia 108
FI - Finlandia 105
RU - Federazione Russa 99
IN - India 97
ID - Indonesia 86
CA - Canada 84
BD - Bangladesh 76
JP - Giappone 58
AR - Argentina 51
NL - Olanda 51
HK - Hong Kong 48
MX - Messico 43
ZA - Sudafrica 38
EC - Ecuador 30
BE - Belgio 28
IQ - Iraq 26
CH - Svizzera 21
SA - Arabia Saudita 21
AT - Austria 19
IL - Israele 18
ES - Italia 17
PK - Pakistan 17
PH - Filippine 16
VE - Venezuela 15
CR - Costa Rica 14
CO - Colombia 13
IR - Iran 12
JM - Giamaica 12
LT - Lituania 12
JO - Giordania 11
MA - Marocco 11
NI - Nicaragua 11
HN - Honduras 10
KR - Corea 10
TN - Tunisia 9
TT - Trinidad e Tobago 9
AU - Australia 8
CZ - Repubblica Ceca 8
GR - Grecia 8
PY - Paraguay 8
SC - Seychelles 8
BG - Bulgaria 7
KZ - Kazakistan 7
PR - Porto Rico 7
RO - Romania 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
BO - Bolivia 6
GT - Guatemala 6
NP - Nepal 6
CI - Costa d'Avorio 5
CL - Cile 5
MY - Malesia 5
NG - Nigeria 5
PE - Perù 5
PT - Portogallo 5
BY - Bielorussia 4
BZ - Belize 4
DZ - Algeria 4
EG - Egitto 4
EU - Europa 4
KE - Kenya 4
LK - Sri Lanka 4
LV - Lettonia 4
TH - Thailandia 4
AM - Armenia 3
AZ - Azerbaigian 3
LB - Libano 3
ML - Mali 3
MU - Mauritius 3
TW - Taiwan 3
ZW - Zimbabwe 3
BB - Barbados 2
BH - Bahrain 2
CM - Camerun 2
CW - ???statistics.table.value.countryCode.CW??? 2
DK - Danimarca 2
ET - Etiopia 2
GP - Guadalupe 2
IS - Islanda 2
KG - Kirghizistan 2
MD - Moldavia 2
MZ - Mozambico 2
OM - Oman 2
QA - Qatar 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
Totale 13.687
Città #
Singapore 676
Ashburn 672
San Jose 532
Chandler 498
Warsaw 190
Jacksonville 186
Ann Arbor 161
New York 139
Dublin 137
Nanjing 135
Beijing 133
Fairfield 128
Milan 123
Chicago 113
San Mateo 111
Woodbridge 103
Wilmington 100
Munich 96
Houston 95
Ho Chi Minh City 90
Kraków 86
The Dalles 84
Izmir 77
Jakarta 75
Los Angeles 75
Lauterbourg 73
Hanoi 69
Rome 68
Cattolica 67
Council Bluffs 66
Nürnberg 65
Seattle 64
Nanchang 61
Boston 60
Dearborn 58
Dallas 56
São Paulo 51
Tokyo 51
Frankfurt am Main 49
Hefei 49
Moscow 45
North Bergen 45
Hong Kong 44
Santa Clara 44
Lawrence 39
Helsinki 37
Buffalo 35
Bremen 33
Princeton 33
Cambridge 29
Lancaster 27
Orem 27
Brussels 26
Marseille 26
Redwood City 26
Phoenix 24
Hangzhou 23
Johannesburg 23
Kunming 23
Brooklyn 22
Changsha 22
Tianjin 21
Guangzhou 20
Montreal 20
Mountain View 20
Norwalk 20
Boardman 19
Da Nang 19
Nuremberg 19
Leawood 18
Rio de Janeiro 18
San Francisco 18
Verona 18
Falls Church 17
Manchester 17
Naples 17
London 16
Paris 16
Philadelphia 16
Redmond 16
Shenyang 16
University Park 16
Atlanta 15
Jiaxing 15
Washington 15
Zurich 15
Kent 14
Belo Horizonte 13
Brasília 13
Hebei 13
San Diego 13
St Louis 13
Toronto 13
Vienna 13
Fremont 12
Pune 12
Quito 12
Stockholm 12
Zhengzhou 12
Las Vegas 11
Totale 6.988
Nome #
Outbreak of Saprochaete clavata Sepsis in Hematology Patients: Combined Use of MALDI-TOF and Sequencing Strategy to Identify and Correlate the Episodes 490
Potential Use of MALDI-ToF Mass Spectrometry for Rapid Detection of Antifungal Resistance in the Human Pathogen Candida glabrata 350
Molecular characterization of human adenoviruses isolated in Italy 342
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study 327
(1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: An observational study 321
Antifungal Susceptibility Profiles of Bloodstream Yeast Isolates by Sensititre YeastOne: a Nine-Year Experience at a Large Italian Teaching Hospital 310
A rapid diagnostic workflow for cefotaxime-resistant Escherichia coli and Klebsiella pneumoniae detection from blood cultures by MALDI-TOF mass spectrometry 296
(1,3)-β-d-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: A randomized trial 277
Comparative Evaluation of BD Phoenix and Vitek 2 Systems for Species Identification of Common and Uncommon Pathogenic Yeasts 260
Application of MALDI-TOF mass spectrometry in clinical diagnostic microbiology 253
Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome 251
Diagnosis of invasive aspergillosis by a commercial real-time PCR assay for Aspergillus DNA in bronchoalveolar lavage fluid samples from high-risk patients compared to a galactomannan enzyme immunoassay 227
Development and Validation of an In-House Database for Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry-Based Yeast Identification Using a Fast Protein Extraction Procedure 224
Analysis of heat-induced changes in protein expression of Stenotrophomonas maltophilia K279a reveals a role for GroEL in the host-temperature adaptation 215
Comparative performance evaluation of Wako β-glucan test and Fungitell assay for the diagnosis of invasive fungal diseases 215
In vitro susceptibilities to seven antifungal agents of Candida lusitaniae isolates from an Italian university hospital 207
Prevalence and Clonal Distribution of Azole-Resistant Candida parapsilosis Isolates Causing Bloodstream Infections in a Large Italian Hospital 207
Antifungal susceptibility profiles of bloodstream yeast isolates by Sensititre YeastOne over nine years at a large Italian teaching hospital 199
A Laboratory-Developed Assay for the Simultaneous Detection of Aspergillus fumigatus and Pneumocystis jirovecii Pulmonary Pathogens 194
Reliability of the Vitek 2 yeast susceptibility test for detection of in vitro resistance to fluconazole and voriconazole in clinical isolates of Candida albicans and Candida glabrata 191
BIOF–HILO assay: A new MALDI–TOF mass spectrometry based method for discriminating between high-and low-biofilm-producing candida parapsilosis isolates 191
Different detection capabilities by mycological media for Candida isolates from mono- or dual-species cultures 190
Rapid Antifungal Susceptibility Testing by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Analysis 184
Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) for identification and clustering of Neisseria gonorrhoeae 184
Direct MALDI-TOF MS Testing from Positive Blood Cultures for Rapid Identification of Bloodstream Infection-Causing Anaerobic Bacteria 183
Comparative Evaluation of the Bruker Biotyper and Vitek MS Matrix-Assisted Laser Desorption Ionization-Time Of Flight (MALDI-TOF) Mass Spectrometry Systems for Identification of Yeasts of Medical Importance 182
Use of microelectronic array technology for rapid identification of clinically relevant mycobacteria 182
Molecular characterization of human adenovirus isolated in Italy 180
Genome-wide expression profiling of the response to short-term exposure to fluconazole in Cryptococcus neoformans serotype A 178
Antifungal susceptibility testing: current role from the clinical laboratory perspective 177
Clusters of patients with candidaemia due to genotypes of Candida albicans and Candida parapsilosis: differences in frequency between hospitals 174
Species identification of Aspergillus, Fusarium and Mucorales with direct surface analysis by matrix-assisted laser desorption ionization time-of-flight mass spectrometry 173
Candida utilis catheter-related bloodstream infection 169
T2Bacteria magnetic resonance assay for the rapid detection of ESKAPEc pathogens directly in whole blood 169
Pan-echinocandin-resistant candida glabrata bloodstream infection complicating covid-19: A fatal case report 167
Microbiologic and clinical characteristics of biofilm-forming Candida parapsilosis isolates associated with fungaemia and their impact on mortality 159
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 158
Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxis 158
In vitro activities of amphotericin B and AmBisome against Aspergillus isolates recovered from Italian patients treated for haematological malignancies 156
Old and New Insights into Sporothrix schenckii Complex Biology and Identification 155
MALDI-TOF mass spectrometry in the clinical mycology laboratory: identification of fungi and beyond 154
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 153
Molecular study of genes involved in virulence regulatory pathways in Bacillus anthracis vaccine strain Carbosap 152
Are We Ready for Nosocomial Candida auris Infections? Rapid Identification and Antifungal Resistance Detection Using MALDI-TOF Mass Spectrometry May Be the Answer 152
Update on the laboratory diagnosis of invasive fungal infections 145
Susceptibility Testing of Common and Uncommon Aspergillus Species Against Posaconazole and Other Mold-Active Antifungal Azoles Using the Sensititre Method 145
First case of breakthrough pneumonia due to Aspergillus nomius in a patient with acute myeloid leukemia 143
Targeted gene disruption in Candida parapsilosis demonstrates a role for CPAR2_404800 in adhesion to a biotic surface and in a murine model of ascending urinary tract infection 143
Considerations on antimicrobial prophylaxis in patients with lymphoproliferative diseases: A SEIFEM group position paper 142
Prognostic value of serial (1,3)-β-d-glucan measurements in ICU patients with invasive candidiasis 140
Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan 140
Uncommon Neosartorya udagawae fungus as a causative agent of severe corneal infection 137
A new pcr‐based assay for testing bronchoalveolar lavage fluid samples from patients with suspected pneumocystis jirovecii pneumonia 137
Chip-Based Molecular Evaluation of a DNA Extraction Protocol for Candida Species from Positive Blood Cultures 136
Advancing Dermatomycosis Diagnosis: Evaluating a Microarray-Based Platform for Rapid and Accurate Fungal Detection—A Pilot Study 135
Identification and typing of the Candida parapsilosis complex: MALDI-TOF MS vs. AFLP 135
Molecular detection of resistance to echinocandins 131
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 130
Validation of a pXO2-A PCR assay to explore diversity among Italian isolates of Bacillus anthracis strains closely related to the live, attenuated Carbosap vaccine 128
The PavA-Like Fibronectin-Binding Protein of Enterococcus faecalis, EfbA, is Important for Virulence in a Mouse Model of Ascending Urinary Tract Infection 128
Use of SCW4 gene primers in PCR methods for the identification of six medically important Aspergillus species 128
Developments in identifying and managing mucormycosis in hematologic cancer patients 127
Molecular detection of resistance to azole components 125
Disseminated geosmithia argillacea infection in a patient with ph-positive acute lymphoblastic leukemia. Case report and literature review 124
Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry-Based Method for Discrimination between Molecular Types of Cryptococcus neoformans and Cryptococcus gattii 120
Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in comparison to rpoB gene sequencing for species identification of bloodstream infection staphylococcal isolates 120
Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in comparison to rpoB gene sequencing for species identification of bloodstream infection staphylococcal isolates 118
“CORE” a new assay for rapid identification of Klebsiella pneumoniae COlistin REsistant strains by MALDI-TOF MS in positive-ion mode 114
Comparable Serum and Plasma 1,3-β-D-Glucan Values Using the Wako β-Glucan Test Assay in Patients with Probable or Proven Fungal Diseases 112
Use of matrix-assisted laser desorption ionization-time of flight mass spectrometry for caspofungin susceptibility testing of Candida and Aspergillus species 108
Gastrointestinal basidiobolomycosis in a patient suffering from duodenal ulcer with perforation: First case report from Italy 108
Typing of Nosocomial Outbreaks of Acinetobacter baumannii by Use of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry 104
Diagnosis of Nocardia paucivorans central nervous system infection by DNA sequencing from paraffin-embedded tissue 104
Evaluation of mass spectrometry detection of pan-fungal serum disaccharide (MS-DS) for the diagnosis of invasive fungal infections: results from a collaborative study involving six European clinical centres 104
Genetic diversity of bacterial strains isolated from soils, contaminated with polycyclic aromatic hydrocarbons, by 16S rRNA gene sequencing and amplified fragment length polymorphism fingerprinting 101
Histoplasmosis in a lung transplant recipient from a nonendemic area 97
Infection caused by Sporothrix schenckii: an autochthonous case in Bari, Southern Italy 87
Correction for Cornu et al., “Evaluation of mass spectrometry-based detection of panfungal serum disaccharide for diagnosis of invasive fungal infections: Results from a collaborative study involving six European clinical centers”. (J Clin Microbiol (2019) 57, 5 (e01867-18) DOI: 10.1128/JCM.01867-18) 86
T2Bacteria magnetic resonance assay for the rapid detection of ESKAPEc pathogens directly in whole blood 82
Evaluation of the VITEK® MS PRIME system for routine identification of bacteria, yeasts, and molds in a tertiary care hospital laboratory 70
Integrating Machine Learning and Molecular Methods for Trichophyton indotineae Identification and Resistance Profiling Using MALDI-TOF Spectra 29
Diagnostic and clinical management of Candida auris infections in immunocompromised patients. 25
Follow the Path: Unveiling an Azole Resistant Candida parapsilosis Outbreak by FTIR Spectroscopy and STR Analysis 22
Totale 13.846
Categoria #
all - tutte 50.326
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.326


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022614 0 0 0 0 56 42 20 125 52 49 150 120
2022/20231.539 231 216 112 207 109 183 53 105 158 86 56 23
2023/2024778 49 212 24 53 56 120 39 32 15 32 62 84
2024/20251.452 51 42 104 67 110 33 74 60 192 177 260 282
2025/20264.070 530 125 253 569 665 196 693 177 338 271 130 123
2026/20271.235 130 171 289 527 118 0 0 0 0 0 0 0
Totale 13.846